Sanofi Fights To Hang On To Eloxatin
In a move to defend its claim to the U.S. market, Sanofi-Aventis U.S. LLC sued Sandoz Inc. Thursday for allegedly infringing a patent for its popular colon cancer drug, which a...To view the full article, register now.
Already a subscriber? Click here to view full article